Intervention, integration and translation in obesity research: Genetic, developmental and metaorganismal approaches

Philosophy, Ethics, and Humanities in Medicine

Volumn 6, Issue 1, 2011, Pages

  O'Malley, Maureen A ^a   Stotz, Karola ^b  

^a UNIVERSITY OF EXETER   (United Kingdom)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ARTICLE; BIOLOGY; GENETICS; HUMAN; MICROBIOLOGY; OBESITY; PATHOPHYSIOLOGY; TRANSLATIONAL RESEARCH;

ANIMALS; COMPUTATIONAL BIOLOGY; HUMANS; OBESITY; TRANSLATIONAL RESEARCH;

EID: 78649975403     PISSN: None     EISSN: 17475341     Source Type: Journal    
DOI: 10.1186/1747-5341-6-2     Document Type: Review

References (165)

1. Cannon B, Nedergaard J. Brown adipose tissue: Function and physiological significance. Physiol Rev 2004, 84:277-359. 10.1152/physrev.00015.2003, 14715917.
2. Trayhurn P, Bing C. Appetite and energy balance from adipocytes. Philos Trans R Soc Lond B Biol Sci 2006, 361:1237-1249. 10.1098/rstb.2006.1859, 1642696, 16815801.
3. Friedman JM. Causes and control of excess body fat. Nature 2009, 459:340-342. 10.1038/459340a, 19458707.
4. Snijder MB, van Dam RM, Visser M, Seidell JC. What aspects of body fat are particularly hazardous and how do we measure them?. Int J Epidemiol 2006, 35:83-92. 10.1093/ije/dyi253, 16339600.
5. James WPT. The epidemiology of obesity: The size of the problem. J Intern Med 2008, 263:336-352. 10.1111/j.1365-2796.2008.01922.x, 18312311.
6. Jutel A. Does size really matter? Weight and values in public health. Persp Biol Med 2001, 44(2):283-296.
7. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006, 295:1549-1555. 10.1001/jama.295.13.1549, 16595758.
8. Oliver JE. The politics of pathology: How obesity became an epidemic disease. Persp Biol Med 2006, 49(4):611-627.
9. Prospective Studies Collaboration Body-mass index and cause-specific mortality in 900,000 adults: Collaborative analyses of 57 prospective studies. Lancet 2009, 373:1083-1096. 10.1016/S0140-6736(09)60318-4, 2662372, 19299006, Prospective Studies Collaboration.
10. Stunkard AJ, Faith MS, Allison KC. Depression and obesity. Biol Psychiatry 2003, 54:330-337. 10.1016/S0006-3223(03)00608-5, 12893108.
11. Puhl R, Brownell KD. Bias, discrimination, and obesity. Obes Res 2001, 9:788-805. 10.1038/oby.2001.108, 11743063.
12. Tunceli K, Li K, Wiilliams LK. Long-term effects of obesity on employment and work limitations among U.S. adults, 1986-1999. Obesity 2006, 14:1637-1646. 10.1038/oby.2006.188, 17030975.
13. Edwards P, Roberts I. Population adiposity and climate change. Int J Epidemiol 2009, 38:1137-1140. 10.1093/ije/dyp172, 19377099.
14. Hill JO, Wyatt HR, Reed JW, Peters JC. Obesity and the environment: Where do we go from here?. Science 2003, 299:853-855. 10.1126/science.1079857, 12574618.
15. Martínez-Harnández A, Enríquez L, Moreno-Moreno MJ, Martí A. Genetics of obesity. Public Health Nutr 2007, 10:1138-1144.
16. Wardle J, Carnell S, Haworth CMA, Plomin R. Evidence for a strong genetic influence on childhood adiposity despite the force of the obesogenic environment. Am J Clin Nutr 2008, 87:398-404.
17. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, et al. Finding the missing heritability of complex diseases. Nature 2009, 461(7265):747-753. 10.1038/nature08494, 2831613, 19812666.
18. Bray GA. Obesity: historical development of scientific and cultural ideas. Int J Obes 1990, 14:909-926.
19. Kennedy GC. The role of depot fat in the hypothalamic control of food intake in the rat. Proc R Soc Lond B Biol Sci 1953, 140:578-92. 10.1098/rspb.1953.0009, 13027283.
20. Mayer J. Regulation of energy intake and the body weight: The glucostatic theory and the lipostatic hypothesis. Ann N Y Acad Sci 1955, 63:15-43. 10.1111/j.1749-6632.1955.tb36543.x, 13249313.
21. Coleman DL, Eicher EM. Fat (fat) and tubby (tub): Two autosomal recessive mutations causing obesity syndromes in the mouse. J Hered 1990, 81:424-427.
22. Friedman JM, Leibel RL, Bahary N. Molecular mapping of obesity genes. Mamm Genome 1991, 1(3):130-144. 10.1007/BF00351059, 1797227.
23. Bouchard C, Pérusse L. Genetics of obesity. Annu Rev Nutr 1993, 13:337-354. 10.1146/annurev.nu.13.070193.002005, 8369150.
24. Price RA, Ness R, Laskarzewski P. Common major gene inheritance of extreme overweight. Hum Biol 1990, 62:747-765.
25. Comuzzie AG, Allison DB. The search for human obesity genes. Science 1998, 280:1374-1377. 10.1126/science.280.5368.1374, 9603720.
26. Tabor HK, Risch NJ, Myers RM. Candidate-gene approaches for studying complex genetic traits. Nat Rev Genet 2002, 3:1-7.
27. Bultman SJ, Michaud EJ, Woychik RP. Molecular characterization of the mouse agouti locus. Cell 1992, 71:1195-1204. 10.1016/S0092-8674(05)80067-4, 1473152.
28. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997, 88:131-141. 10.1016/S0092-8674(00)81865-6, 9019399.
29. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372:425-432. 10.1038/372425a0, 7984236.
30. Coleman DL. Obese and diabetes: Two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 1978, 14:141-148. 10.1007/BF00429772, 350680.
31. Tartaglia LA. The leptin receptor. J Biol Chem 1997, 272:6093-6096.
32. Williams KW, Scott MM, Elmquist JK. From observation to experimentation: Leptin action in the mediobasal hypothalamus. Am J Clin Nutr 2009, 89(Suppl):985S-990S. 10.3945/ajcn.2008.26788D, 2667659, 19176744.
33. Campfield AL, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: Evidence for a peripheral signal linking adiposity and central neural networks. Science 1995, 269:546-549. 10.1126/science.7624778, 7624778.
34. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995, 269:543-546. 10.1126/science.7624777, 7624777.
35. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, et al. Effects of the obese gene product on body weight reduction in ob/ob mice. Science 1995, 269:540-543. 10.1126/science.7624776, 7624776.
36. Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X, Ellis SJ. Evidence that the diabetes gene encodes the leptin receptor: Identification of a mutation in the leptin receptor gene in db/db mice. Cell 1996, 84:491-495. 10.1016/S0092-8674(00)81294-5, 8608603.
37. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, et al. Identification and expression cloning of a leptin receptor, OB-R. Cell 1995, 83:1263-1271. 10.1016/0092-8674(95)90151-5, 8548812.
38. Chicurel M. Whatever happened to leptin?. Nature 2000, 404:538-540. 10.1038/35007253, 10766210.
39. Weintraub A. Inside drugmakers' war on fat. BusinessWeek 2008, http://www.businessweek.com/magazine/content/08_11/b4075040441642.htm
40. Farooqi IS, O'Rahilly S. Genetics of obesity in humans. Endocr Rev 2006, 27:710-718.
41. Friedman JM. Leptin at 14 y of age: An ongoing story. Am J Clin Nutr 2009, 89(Suppl):973S-979S. 10.3945/ajcn.2008.26788B, 2667654, 19190071.
42. Spiegelman BM, Flier JS. Obesity and the regulation of energy balance. Cell 2001, 104:531-543. 10.1016/S0092-8674(01)00240-9, 11239410.
43. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 1998, 395:763-770. 10.1038/27376, 9796811.
44. Frühbeck G. A heliocentric view of leptin. Proc Nutr Soc 2001, 60:301-318.
45. Arch JRS. Central regulation of energy balance: Inputs, outputs and leptin resistance. Proc Nutr Soc 2005, 64:39-46. 10.1079/PNS2004407, 15877921.
46. Scarpace PJ, Zhang Y. Leptin resistance: a prediposing factor for diet-induced obesity. Am J Physiol Regul Integr Comp Physiol 2008, 296:R493-R500. 2665845, 19091915.
47. Flier JS. What's in a name? In search of leptin's physiologic role. J Clin Endocrinol Metab 1998, 83:1407-1413. p. 1407, 10.1210/jc.83.5.1407, 9589630.
48. Ahima RS. Revisiting leptin's role in obesity and weight loss. J Clin Invest 2008, 118:2380-2383. 2430504, 18568083.
49. Otto B, Spranger J, Benoit SC, Clegg DJ, Tschöp MH. The many faces of ghrelin: New perspectives for nutrition research?. Br J Nutr 2005, 93:765-771. 10.1079/BJN20051446, 16022744.
50. Trayhurn P, Wood IS. Adipokines: Inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004, 92:347-355. 10.1079/BJN20041213, 15469638.
51. Badman MK, Flier JS. The gut and energy balance: Visceral allies in the obesity wars. Science 2005, 307:1909-1914. 10.1126/science.1109951, 15790843.
52. Vásquez-Vela MEF, Torres N, Tovar AR. White adipose tissue as endocrine organ and its role in obesity. Arch Med Res 2008, 39:715-728.
53. Nedergaard J, Cannon B. The changed metabolic world with human brown adipose tissue: Therapeutic visions. Cell Metab 2010, 11:268-272. 10.1016/j.cmet.2010.03.007, 20374959.
54. Cancello R, Clément K. Is obesity an inflammatory illness? Role of low-grade inflammation and macrophage infiltration in human white adipose tissue. BJOG 2006, 113:1141-1147. 10.1111/j.1471-0528.2006.01004.x, 16903845.
55. Dandona P, Aljada A, Bandyopadhyay A. Inflammation: The link between insulin resistance, obesity and diabetes. Trends Immunol 2004, 25:4-7. 10.1016/j.it.2003.10.013, 14698276.
56. Xu H, Barnes GT, Yang Q, Tan G, Yang D, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003, 112:1821-1830. 296998, 14679177.
57. Bell CG, Walley AJ, Froguel P. The genetics of human obesity. Nat Rev Genet 2005, 6:221-234. 10.1038/nrg1556, 15703762.
58. Pearson TA, Manolio TA. How to interpret a genome-wide association study. JAMA 2008, 299:1335-1344. 10.1001/jama.299.11.1335, 18349094.
59. Hattersley AT, McCarthy M. What makes a good association study?. Lancet 2005, 366:1315-1323. 10.1016/S0140-6736(05)67531-9, 16214603.
60. Church C, Lee S, Bagg EA, McTaggart JS, Deacon R, et al. A mouse model for the metabolic effects of the human fat mass and obesity associated FTO gene. PLoS Genet 2009, 5(8):e1000599. 10.1371/journal.pgen.1000599, 2719869, 19680540.
61. Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007, 316:889-894. 10.1126/science.1141634, 2646098, 17434869.
62. Shin AC, Zheng H, Berthoud H-R. An expanded view of energy homeostasis: Neural integration of metabolic, cognitive, and emotional drives to eat. Physiol Behav 2009, 97:572-580. 10.1016/j.physbeh.2009.02.010, 2765252, 19419661.
63. Wang Y, Lobstein T. Worldwide trends in childhood overweight and obesity. Int J Pediatr Obes 2006, 1(1):11-25. 10.1080/17477160600586747, 17902211.
64. Gerken T, Girard CA, Tung Y-CL, Webby CJ, Saudek V, et al. The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nuclei acid demethylase. Science 2007, 318:1469-1472. 10.1126/science.1151710, 2668859, 17991826.
65. Neel JV. Diabetes mellitus: A 'thrifty' genotype rendered detrimental by 'progress'?. Am J Hum Genet 1962, 14:353-362. 1932342, 13937884.
66. Paradies YC, Montoya MJ, Fullerton SM. Racialized genetics and the study of complex diseases: The thrifty phenotype revisited. Persp Biol Med 2007, 50(2):203-227.
67. Speakman JR. A nonadaptive scenario explaining the genetic predisposition to obesity: The 'predation release' hypothesis. Cell Metab 2007, 6:5-12. 10.1016/j.cmet.2007.06.004, 17618852.
68. Barker DJ, Osmond C. Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet 1986, 1:1077-1081. 10.1016/S0140-6736(86)91340-1, 2871345.
69. Barker DJ, Hales CN, Fall CHD, Osmond C, Phipps K, Clark PMS. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 1993, 36:62-7. 10.1007/BF00399095, 8436255.
70. Barker DJ, Forsén T, Uutela A, Osmond C, Eriksson JG. Size at birth and resilience to effects of poor living conditions in adult life: longitudinal study. Br Med J 2001, 323:1273-1276.
71. Hales CN, Barker DJ. The thrifty phenotype hypothesis. Br Med Bull 2001, 60:5-20. 10.1093/bmb/60.1.5, 11809615.
72. Gluckman PD, Hanson MA. Living with the past: evolution, development, and patterns of disease. Science 2004, 305:1733-1736. 10.1126/science.1095292, 15375258.
73. Gluckman PD, Hanson MA. The Fetal Matrix: Evolution, Development and Disease. 2005, Cambridge: Cambridge University Press.
74. Gluckman PD, Hanson MA. Developmental and epigenetic pathways to obesity: an evolutionary-developmental perspective. Int J Obes 2008, 32:S62-S71.
75. Vickers MH, Breier BH, Cutfield WS, Hofman PL, Gluckman PD. Fetal origins of hyperphagia, obesity and hypertension and its postnatal amplification by hypercaloric nutrition. Am J Physiol 2000, 279:E83-E87.
76. Gluckman PD, Hanson MA. Developmental Origins of Health and Disease. 2005, Cambridge: Cambridge University Press.
77. Nathanielsz PW, Thornburg KL. Fetal programming: from gene to functional systems -- an overview. J Physiol 2003, 547:3-4.
78. Noble D. The Music of Life: Biology Beyond Genes. 2008, Oxford: Oxford University Press.
79. Gluckman PD, Hanson MA. Mismatch: Why Our World No Longer Fits Our Bodies. 2006, Oxford: Oxford University Press.
80. Waddington, 1942, cited in Haig D The (dual) origin of epigenetics. Cold Spring Harbor Symposia on Quantitative Biology 2004, 69:67-70. 10.1101/sqb.2004.69.67, 16117634, Waddington, 1942, cited in Haig D.
81. Painter RC, Roseboom TJ, Bleker OP. Prenatal exposure to the Dutch famine and disease in later life: an overview. Reprod Toxicol 2005, 20:345-352. 10.1016/j.reprotox.2005.04.005, 15893910.
82. Heijmans BT, Tobi EW, Stein AD, Putter H, Blauw GJ, et al. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci USA 2008, 105:17046-17049. 10.1073/pnas.0806560105, 2579375, 18955703.
83. Kwong WY, Wild AE, Roberts P, Willis AC, Fleming TP. Maternal undernutrition during the preimplantation period of rat development causes blastocyst abnormalities and programming of postnatal hypertension. Dev Psychol 2000, 127:4195-4202.
84. Young LE, Fernandes K, McEvoy TG, Butterwith SC, Gutierrez CG, et al. Epigenetic change in IGF2R is associated with fetal overgrowth after sheep embryo culture. Nat Genet 2001, 27:153-154. 10.1038/84769, 11175780.
85. McGowan PO, Meaney MJ, Szyf M. Diet and the epigenetic (re)programming of phenotypic differences in behavior. Brain Res 2008, 1237:12-24. 10.1016/j.brainres.2008.07.074, 2951010, 18694740.
86. O'Regan D, Welberg LL, Holmes MC, Seckl JR. Glucocorticoid programming of pituitary-adrenal function: mechanisms and physiological consequences. Semin Neonatol 2001, 6:319-329.
87. Hu J-F, Nguyen PH, Pham NV, Vu TH, Hoffman AR. Modulation of Igf2 genomic imprinting in mice induced by 5-azacytidine, an inhibitor of DNA methylation. Mol Endocrinol 1997, 11:1891-1898. 10.1210/me.11.13.1891, 9415394.
88. Gluckman PD, Hanson MA, Beedle AS. Non-genomic transgenerational inheritance of disease risk. BioEssays 2007, 29(2):145-154. 10.1002/bies.20522, 17226802.
89. Fish EW, Shahrokh D, Bagot R, Caldji C, Bredy T, Szyf M, Meaney MJ. Epigenetic programming of stress responses through variations in maternal care. Ann NY Acad Sci 2004, 1036:167-180. 10.1196/annals.1330.011, 15817737.
90. Vickers MH, Gluckman PD, Coveny AH, Hofman PL, Cutfield WS, et al. Neonatal leptin treatment reverses developmental programming. Endocrinology 2005, 146:4211-4216. 10.1210/en.2005-0581, 16020474.
91. Szyf M, McGowan PO, Meaney MJ. The social environment and the epigenome. Environ Mol Mutagen 2008, 49:46-60. 10.1002/em.20357, 18095330.
92. Lu Q, Qiu X, Hu N, Wen H, Su Y, Richardson BC. Epigenetics, disease, and therapeutic interventions. Ageing Res Rev 2006, 5:449-467. 10.1016/j.arr.2006.07.001, 16965942.
93. Weaver IC. Epigenetic programming by maternal behavior and pharmacological intervention. Nature versus nurture: let's call the whole thing off. Epigenetics 2007, 2(1):22-8. 10.4161/epi.2.1.3881, 17965624.
94. Savage DC. Microbial ecology of the gastrointestinal tract. Ann Rev Microbiol 1977, 31:107-133.
95. Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI. Molecular analysis of commensal host-microbial relationships in the intestine. Science 2001, 291:881-884. 10.1126/science.291.5505.881, 11157169.
96. McFall-Ngai MJ. Unseen forces: The influence of bacteria on animal development. Dev Biol 2002, 242:1-14. 10.1006/dbio.2001.0522, 11795936.
97. Gill SR, Pop M, Deboy RT, Eckburg PB, Turnbaugh PJ, et al. Metagenomic analysis of the human distal gut microbiome. Science 2006, 312:1355-1359. 10.1126/science.1124234, 3027896, 16741115.
98. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464:59-65. 10.1038/nature08821, 20203603.
99. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. The Human Microbiome Project. Nature 2007, 449:804-810. 10.1038/nature06244, 17943116.
100. Neish AS. Microbes in gastrointestinal health and disease. Gastroenterology 2009, 136:65-80. 10.1053/j.gastro.2008.10.080, 2892787, 19026645.
101. Turnbaugh PJ, Bäckhed F, Fulton L, Gordon JI. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host & Microbe 2008, 3:213-223.
102. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L. Diversity of the human intestinal microbial flora. Science 2005, 308:1635-1638. 10.1126/science.1110591, 1395357, 15831718.
103. Hooper LV. Do symbiotic bacteria subvert host immunity?. Nat Rev Microbiol 2009, 7:367-374. 10.1038/nrmicro2114, 19369952.
104. Bäckhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 2004, 101:15718-15723. 524219, 15505215.
105. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444:1027-1031. 10.1038/nature05414, 17183312.
106. Samuel BS, Gordon JI. A humanized gnotobiotic mouse model of host-archaeal-bacterial mutualism. Proc Natl Acad Sci USA 2006, 103(26):10011-10016. 10.1073/pnas.0602187103, 1479766, 16782812.
107. Turnbaugh PJ, Gordon JI. An invitation to the marriage of metagenomics and metabolomics. Cell 2008, 134:708-713. 10.1016/j.cell.2008.08.025, 18775300.
108. Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 2005, 102:11070-11075. 10.1073/pnas.0504978102, 1176910, 16033867.
109. Duncan SH, Lobley GE, Holtrop G, Ince J, Johnstone AM, et al. Human colonic microbiota associated with diet, obesity and weight loss. Int J Obes 2008, 32:1720-1724.
110. Bäckhed F, Manchester JK, Semenkovich CF, Gordon JI. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci USA 2007, 104:979-984. 1764762, 17210919.
111. Mahowald MA, Rey FE, Seedorf H, Turnbaugh PJ, Fulton RS, et al. Characterizing a model human gut microbiota composed of members of its two dominant phyla. Proc Natl Acad Sci USA 2009, 106(14):5859-5864. 10.1073/pnas.0901529106, 2660063, 19321416.
112. Samuel BS, Hansen EE, Manchester JK, Coutinho PM, Henrissat B, et al. Genomic and metabolic adaptations of Methanobrevibacter smithii to the human gut. Proc Natl Acad Sci USA 2007, 104(25):10643-10648. 10.1073/pnas.0704189104, 1890564, 17563350.
113. Turnbaugh PJ, et al. A core gut microbiome in obese and lean twins. Nature 2009, 457:480-484. 10.1038/nature07540, 2677729, 19043404.
114. Khachatryan ZA, Ktsoyan ZA, Manukyan GP, Kelly D, Ghazaryan KA, Aminov RI. Predominant role of host genetics in controlling the composition of gut microbiota. PLoS One 2008, 3(8).
115. Xu J, Gordon JI. Honor thy symbionts. Proc Natl Acad Sci USA 2003, 100(18):10452-10459. 10.1073/pnas.1734063100, 193582, 12923294.
116. Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO. Development of the human infant intestinal microbiota. PLoS Biol 2007, 5(7):e177. 10.1371/journal.pbio.0050177, 1896187, 17594176.
117. Kalliomäki M, Collado MC, Salminen S, Isolauri E. Early differences in fecal microbiota composition in children may predict overweight. Am J Clin Nutr 2008, 87:534-538.
118. Wen L, Ley RE, Volchkov PY, Stranges PB, Avanesyan L, et al. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 2008, 455(7216):1109-13. 10.1038/nature07336, 2574766, 18806780.
119. Zhang H, DiBaise JK, Zuccolo A, Kudrna D, Braidotti M, et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci USA 2009, 106:2365-2370. 10.1073/pnas.0812600106, 2629490, 19164560.
120. Jia W, Li H, Zhao L, Nicholson JK. Gut microbiota: A potential new territory for drug targeting. Nat Rev Drug Discov 2008, 7(2):123-129. 10.1038/nrd2505, 18239669.
121. Vijay-Kumar M, Aitken JD, Carvalho FA, Cullender TC, Mwangi S, et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 2010, 328:228-231. 10.1126/science.1179721, 20203013.
122. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008, 57(6):1470-1481. 10.2337/db07-1403, 18305141.
123. Mazmanian SK, Round JL, Kasper DL. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 2008, 453:620-625. 10.1038/nature07008, 18509436.
124. NIH HMP Working Group The NIH Human Microbiome Project. Genome Res 2009, 19:2317-2323. 10.1101/gr.096651.109, 2792171, 19819907, NIH HMP Working Group.
125. Mai V, Draganov PV. Recent advances and remaining gaps in our knowledge of associations between gut microbiota and human health. World J Gastroenterol 2009, 15(1):81-85. 10.3748/wjg.15.81, 2653298, 19115471.
126. Delzenne N, Reid G. No causal link between obesity and probiotics. Nat Rev Microbiol 2009,
127. Blaser MJ, Falkow S. What are the consequences of the disappearing human microbiota?. Nat Rev Microbiol 2009, 7:887-894. 10.1038/nrmicro2245, 19898491.
128. Nicholson JK, Holmes E, Lindon JC, Wilson ID. The challenges of modelling mammalian biocomplexity. Nat Biotechnol 2004, 22(10):1268-1274. 10.1038/nbt1015, 15470467.
129. Ley RE, Peterson DA, Gordon JI. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 2006, 124:837-848. 10.1016/j.cell.2006.02.017, 16497592.
130. Savage DC. Microbial biota of the human intestine: A tribute to some pioneering scientists. Curr Issues Intest Microbiol 2001, 2(1):1-15.
131. Ley RE, Lozupone CA, Hamady M, Knight R, Gordon JI. Worlds within worlds: Evolution of the vertebrate gut microbiota. Nat Rev Microbiol 2008, 6:776-788. 10.1038/nrmicro1978, 2664199, 18794915.
132. Xu J, Mahowald MA, Ley RE, Lozupone CA, Hamady M, et al. Evolution of symbiotic bacteria in the distal human intestine. PLoS Biol 2007, 5:e156. 10.1371/journal.pbio.0050156, 1892571, 17579514.
133. Haemer MA, Huang TT, Daniels SR. The effect of neurohormonal factors, epigenetic factors, and gut microbiota on risk of obesity. Prev Chronic Dis 2009, 6(3). 2722400, 19527597., http://www.cdc.gov/pcd/issues/2009/jul/09_0011.htm
134. Hammond RA. Complex systems modelling for obesity research. Prev Chronic Dis 2009, 6(3):1-10.
135. Schaffner KF. Reductionism, complexity and molecular medicine: genetic chips and the 'globalization' of the genome. Promises and Limits of Reductionism in the Biomedical Sciences 2002, 323-351. London: John Wylie, van Regenmortel MHV, Hull DL.
136. Tauber AI. The ethical imperative of holism and medicine. Promises and Limits of Reductionism in the Biomedical Sciences 2002, 261-278. London: John Wylie, van Regenmortel MHV, Hull DL.
137. Khushf G. Health as intra-systemic integrity: Rethinking the foundations of systems biology and nanomedicine. Persp Biol Med 2008, 51:432-449.
138. Craver CF. Explaining the Brain: Mechanisms and the Mosaic Unity of Neuroscience. 2007, New York: Oxford University Press.
139. Woodward J. Making Things Happen. 2003, Oxford: Oxford University Press.
140. Mitchell SD. Unsimple Truths: Science, Complexity, And Policy. 2009, Chicago: University of Chicago Press.
141. Kraus D, Herman MA, Kahn BB. Leveraging leptin for type 1 diabetes?. Proc Natl Acad Sci USA 2010, 107:4793-4792. 10.1073/pnas.1000736107, 2841872, 20212134.
142. Wang M-Y, Chen L, Clark GO, Lee Y, Stevens RD, et al. Leptin therapy in insulin-deficient type 1 diabetes. Proc Natl Acad Sci USA 2010, 107:4813-4819. 10.1073/pnas.0909422107, 2841945, 20194735.
143. Auffray C, Imbeaud S, Roux-Rouquié M, Hood L. From functional genomics to systems biology: Concepts and practices. Comptes Rendus Biologies 2003, 326:879-892. 10.1016/j.crvi.2003.09.033, 14744094.
144. Bruggeman FJ, Westerhoff HV. The nature of systems biology. Trends Microbiol 2006, 15:45-50. 10.1016/j.tim.2006.11.003, 17113776.
145. Kitano H. Computational systems biology. Nature 2002, 420:206-210. 10.1038/nature01254, 12432404.
146. Stelling J. Mathematical models in microbial systems biology. Curr Opin Microbiol 2004, 7(5):513-518. 10.1016/j.mib.2004.08.004, 15451507.
147. Ahn AC, Tewari M, Poon CS, Phillips RS. The clinical applications of a systems approach. PLOS Med 2009, 3(7):0956-0960.
148. Auffray C, Chen Z, Hood L. Systems medicine: the future of medical genomics and healthcare. Genome Med 2009, 1(1):2.1-2.11.
149. Clermont G, Auffray C, Moreau Y, Rocke DM, Dalevi D, et al. Bridging the gap between systems biology and medicine. Genome Med 2009, 1(9):88.1-88.6.
150. Chen Y, Zhu J, Lum PY, Yang X, Pinto S, et al. Variations in DNA elucidate molecular networks that cause disease. Nature 2008, 452:429-35. 10.1038/nature06757, 2841398, 18344982.
151. Emilsson V, Thorleifsson G, Zhang B, Leonardson AS, Zink F, et al. Genetics of gene expression and its effect on disease. Nature 2008, 452:423-428. 10.1038/nature06758, 18344981.
152. Schadt EE, Lum PY. Reverse engineering gene networks to identify key drivers of complex disease phenotypes. J Lipid Res 2006, 47:2601-2613. 10.1194/jlr.R600026-JLR200, 17012750.
153. Huang TT, Drewnosksi A, Kumanyika S, Glass TA. A systems-oriented multilevel framework for addressing obesity in the 21st century. Prev Chronic Dis 2009, 6(3)., http://www.cdc.gov/pcd/issues/2009/jul/09_0013.htm
154. O'Rahilly S. Human genetics illuminates the paths to metabolic disease. Nature 2009, 462:307-314.
155. Jones D. Novel pharmacotherapies for obesity poised to enter market. Nat Rev Drug Discov 2009, 8:833-834. 10.1038/nrd3044, 19876031.
156. Duyk G. Attrition and translation. Science 2003, 302:603-605. 10.1126/science.1090521, 14576424.
157. Fang FC, Casadevall A. Lost in translation -- Basic science in the era of translational research. Infect Immun 2010, 78:563-566. 10.1128/IAI.01318-09, 2812192, 20038540.
158. Wehling M. Translational medicine: Can it really facilitate the transition of research 'from bench to bedside'?. Eur J Clin Pharmacol 2006, 62:91-95. 10.1007/s00228-005-0060-4, 16344921.
159. Marincola FM. Translational medicine: A two-way road. J Transl Med 2003, 1:1. 10.1186/1479-5876-1-1, 202357, 14527344., http://www.translational-medicine.com/content/1/1/1
160. Zerhouni EA. Translational research: Moving discovery to practice. Clin Pharmacol Ther 2007, 81:126-128. 10.1038/sj.clpt.6100029, 17186011.
161. Calvert J. What's special about basic research?. Sci Technol Human Values 2006, 31(2):199-220.
162. Reagan MD. Basic and applied research: A meaningful distinction?. Science 1967, 155:1383-1386. 10.1126/science.155.3768.1383, 6018503.
163. Sintonen M. Basic and applied sciences -- can the distinction (still) be drawn?. Sci Stud 1990, 2:23-31.
164. Stotz K, Griffiths PE. Biohumanities: Rethinking the relationship between biosciences, philosophy and history of science, and society. Q Rev Biol 2008, 83(1):37-45. 10.1086/529561, 18481587.
165. Worrall J. Evidence and ethics in medicine. Persp Biol Med 2008, 51:418-431.